JPRN-UMIN000029635已完成未知
Safety and efficacy of lenalidomide for patients with relapsed or refractory adult T cell leukemia/lymphoma post allogeneic hematopoietic stem cell transplantation, multi-institutional prospective observational trial - Safety and efficacy of lenalidomide for relapsed or refractory ATL post allo-SCT
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 33
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. History of lenalidomide administration after allogeneic hematopoietic stem cell transplantation 2. Plant to move within one year after registry 3. Inappropriate condition by physician's decision 4. Pregnancy or under breast-feeding or plat to pregnant during registry
研究者
相似试验
进行中（未招募）
不适用
Evaluation of efficacy and safety of Lenalidomide (Revlimid) in patients with POEMS Syndrome - ONC-2008-002POEMS SYNDROMEMedDRA version: 9.1Level: SOCClassification code 10029205EUCTR2008-003202-33-ITISTITUTO CLINICO HUMANITAS
进行中（未招募）
不适用
Safety and efficacy of levosimendan in patients with acute myocardial infarction complicated by symptomatic left ventricular failureEUCTR2004-002732-25-NOGeir Øystein Andersen, Department of Cardiology, Ulleval University Hospital
已完成
2 期
Efficacy and safety of dose-escalating lenalidomide and dexamethasone (Rd) for unfit patients with relapsed or refractory multiple myelomanfit patients with relapsed or refractory multiple myelomaJPRN-UMIN000019917Gifu University Hospital20
进行中（未招募）
1 期
The purpose of the study is to determine if the drug lenalidomide (Revlimid®) is able to improve anaemia (low red blood count) and reduce the number of blood transfusions that you require because of Myelodysplastic Syndrome (MDS). The other purpose of the study is to evaluate the effect of the study drug (lenalidomide) on the genetic abnormality (changes in the cell characteristics) associated with MDS.Myelodysplastic Syndrome (MDS) associated with a Del (5q) cytogenetic abnormalityMedDRA version: 16.0 Level: LLT Classification code 10067097 Term: 5q minus MDS System Organ Class: 100000004864EUCTR2004-005101-29-GBKing's College Hospital NHS Foundation Trust44
已完成
1 期
Safety and efficacy of lenalidomide cyclophosphamide and dexamethasone (RCd) therapy in Japanese elderly patients with multiple myeloma, a phase I/II studyMultiple MyelomaJPRN-UMIN000009391KT-MM30